Edit |   |
---|---|
Product Name | Recombinant human Kallikrein 7/KLK7 protein |
Description | Domain: 30-253aa. Recombinant human KLK7 protein, fused to His-tag at N-terminus, was expressed in E. coli. MW: 27.1 kDa (249aa). Purity > 90% by SDS-PAGE. KLK7 is a member of the kallikrein subfamily of serine proteases. These enzymes have diverse physiological functions and many kallikreins are biomarkers for cancer. The protein has chymotrypsin-like activity and plays a role in the proteolysis of intercellular cohesive structures that precedes desquamation, the shedding of the outermost layer of the epidermis. KLK7 may play a role in cancer invasion and metastasis, and increased expression of this protein is associated with unfavorable prognosis and progression of several types of cancer. Polymorphisms in this gene may play a role in the development of atopic dermatitis |
Size | 20ug, 100ug, 500ug |
Concentration | 1mg/ml (determined by Bradford assay) |
Applications | SDS-PAGE, Denatured |
Other Names | Stratum corneum chymotryptic enzyme, Serine protease 6, SCCE, PRSS6, KLK7, Kallikrein-7 isoform 2, Kallikrein-7, Kallikrein related peptidase 7, HK7 |
Gene, Accession, CAS # | NCBI: NP_005037, UniProt: P49862 |
Catalog # | ATGP1737 |
Price | $80, $240, $720 |
Order / More Info | Recombinant human Kallikrein 7/KLK7 protein from NKMAX Co. Ltd. |
Product Specific References | n/a |